AU2008275852B2 - Antimicrobial composition - Google Patents

Antimicrobial composition Download PDF

Info

Publication number
AU2008275852B2
AU2008275852B2 AU2008275852A AU2008275852A AU2008275852B2 AU 2008275852 B2 AU2008275852 B2 AU 2008275852B2 AU 2008275852 A AU2008275852 A AU 2008275852A AU 2008275852 A AU2008275852 A AU 2008275852A AU 2008275852 B2 AU2008275852 B2 AU 2008275852B2
Authority
AU
Australia
Prior art keywords
treatment
wounds
burns
composition
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008275852A
Other languages
English (en)
Other versions
AU2008275852A1 (en
Inventor
Olga O. Biliaieva
Alexandr A. Golub
Viacheslav V. Neshta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2008275852A1 publication Critical patent/AU2008275852A1/en
Application granted granted Critical
Publication of AU2008275852B2 publication Critical patent/AU2008275852B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0095—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/2404—Serralysin (3.4.24.40)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Composite Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU2008275852A 2007-07-12 2008-07-11 Antimicrobial composition Ceased AU2008275852B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
UAU200707897 2007-07-12
UAU200707897U UA28103U (uk) 2007-07-12 2007-07-12 Комплексний сорбційно-протеолітичний препарат сертасил для лікування гнійних ран, трофічних виразок, опіків
PCT/UA2008/000041 WO2009008851A2 (en) 2007-07-12 2008-07-11 Antimicrobial composition

Publications (2)

Publication Number Publication Date
AU2008275852A1 AU2008275852A1 (en) 2009-01-15
AU2008275852B2 true AU2008275852B2 (en) 2014-02-13

Family

ID=55588706

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008275852A Ceased AU2008275852B2 (en) 2007-07-12 2008-07-11 Antimicrobial composition

Country Status (23)

Country Link
US (4) US9302027B2 (enExample)
EP (2) EP2170415B1 (enExample)
JP (1) JP5464750B2 (enExample)
KR (1) KR101482960B1 (enExample)
CN (1) CN101772356B (enExample)
AT (1) ATE488255T1 (enExample)
AU (1) AU2008275852B2 (enExample)
BR (1) BRPI0814549B1 (enExample)
CA (1) CA2693087C (enExample)
CY (1) CY1111652T1 (enExample)
DE (1) DE602008003584D1 (enExample)
DK (1) DK2170415T3 (enExample)
EA (1) EA016764B1 (enExample)
ES (1) ES2353683T3 (enExample)
HR (1) HRP20110107T1 (enExample)
MX (1) MX2010000367A (enExample)
MY (1) MY148077A (enExample)
PL (1) PL2170415T3 (enExample)
PT (1) PT2170415E (enExample)
SI (1) SI2170415T1 (enExample)
UA (1) UA28103U (enExample)
WO (1) WO2009008851A2 (enExample)
ZA (1) ZA201000126B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010079209A2 (en) * 2009-01-08 2010-07-15 Golub Alexandr A Compositions for treating wounds and skin conditions
MD4197C1 (ro) * 2012-10-22 2013-09-30 Мария ДАНУ Metodă de tratament al ulcerelor trofice
CN102961336B (zh) * 2012-12-13 2014-08-13 清华大学深圳研究生院 纳米级铂类药物及其制备方法
BR112016010351A2 (pt) * 2013-11-06 2017-08-08 Invenres Gmbh Composições em forma de pó, métodos de produção de uma composição em forma de pó, preparação farmacêutica, e artigo médico
EP3215129A2 (en) * 2014-11-04 2017-09-13 invenres GmbH Pharmaceutical preparation and method of its production and use
CN106558599B (zh) * 2015-09-29 2020-04-07 中芯国际集成电路制造(上海)有限公司 电阻随机存取存储器及其形成方法
JP7475052B2 (ja) 2018-01-29 2024-04-26 パテレン・ヘルス・ケア・アクチェンゲゼルシャフト 親水性／疎水性薬学的組成物、ならびにその産生法および使用法
CN108309941B (zh) * 2018-03-20 2023-08-11 南京工业大学 一种舍雷肽酶外用粉剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792160A (en) * 1972-01-18 1974-02-12 Takeda Chemical Industries Ltd Method of treating inflammation and composition therefor
JPS5826822A (ja) * 1981-08-10 1983-02-17 Kaken Pharmaceut Co Ltd 慢性腎炎治療剤
DK1409034T3 (da) * 2001-07-24 2006-10-30 Advanced Biotechnologies Topisk farmaceutisk formulering

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
D1 : MAHESHWARI, M. et al., "DEVELOPMENT OF TETRACYCLlNESERRATIOPEPTIDASECONTAINING PERIODONTAL GEL: FORMULATION AND PRELIMINARY CLINICAL STUDY." AAPS PHARMSCITECH, 2006, Vol. 7(3), pages E1-E10. *

Also Published As

Publication number Publication date
CA2693087A1 (en) 2009-01-15
EP2170415A2 (en) 2010-04-07
UA28103U (uk) 2007-11-26
PL2170415T3 (pl) 2011-04-29
MX2010000367A (es) 2010-07-02
WO2009008851A3 (en) 2009-11-26
DK2170415T3 (da) 2010-12-13
US10166275B2 (en) 2019-01-01
JP5464750B2 (ja) 2014-04-09
JP2010533174A (ja) 2010-10-21
CY1111652T1 (el) 2015-10-07
KR101482960B1 (ko) 2015-01-15
MY148077A (en) 2013-02-28
WO2009008851A2 (en) 2009-01-15
EP2277559A1 (en) 2011-01-26
PT2170415E (pt) 2011-01-05
US20160206709A1 (en) 2016-07-21
CN101772356A (zh) 2010-07-07
US9757436B2 (en) 2017-09-12
KR20100051655A (ko) 2010-05-17
EP2170415B1 (en) 2010-11-17
EA016764B1 (ru) 2012-07-30
EA201070130A1 (ru) 2010-08-30
CN101772356B (zh) 2013-05-08
ES2353683T3 (es) 2011-03-04
AU2008275852A1 (en) 2009-01-15
US20100291062A1 (en) 2010-11-18
CA2693087C (en) 2016-08-16
DE602008003584D1 (de) 2010-12-30
ATE488255T1 (de) 2010-12-15
HRP20110107T1 (hr) 2011-03-31
ZA201000126B (en) 2011-04-28
US20170368154A1 (en) 2017-12-28
SI2170415T1 (sl) 2011-02-28
BRPI0814549B1 (pt) 2018-07-03
US20150297787A1 (en) 2015-10-22
BRPI0814549A2 (pt) 2017-10-03
US9302027B2 (en) 2016-04-05

Similar Documents

Publication Publication Date Title
US10166275B2 (en) Antimicrobial composition comprising pyrogenic silica and serrathiopeptidase and uses thereof
US20160271294A1 (en) Pharmaceutical preparation and method of its production and use
CN1850291A (zh) 具有促进伤口愈合、抗菌功能的液体伤口敷料
CN105169455B (zh) 一种烧烫伤外用急救医用敷料及其制备方法
El-Naggar et al. Chitosan microflower-embedded gelatin sponges for advanced wound management and hemostatic applications
Thomas 12 Wound Dressings
CN113018499A (zh) 一种杀菌抗病毒吸湿的臭氧油水凝胶复合敷贴的制备方法
EP3215129A2 (en) Pharmaceutical preparation and method of its production and use
Wójcik et al. Bioactive curdlan/agarose dressing enriched with gentamicin for infected wounds–pilot studies
HK1145817A (en) Antimicrobial composition
HK1145817B (en) Antimicrobial composition
RU2455997C2 (ru) Способ лечения инфицированных ожоговых ран iiia степени
Jones Use of hydrogels and iodine in diabetic foot lesions
Foutsizoglou A practical guide to the most commonly used dressings in wound care
UA64934A (en) Complex antibacterial sorption preparation benegol for preventing anaerobic infection and treating purulent wounds, neurepathic eschar, and wounds and method for its manufacture
Beschastnov et al. Evaluation of the Feasibility of Using Commercial Wound Coatings as a Carrier Matrix for Bacteriophages
UA129758C2 (uk) Композиція для обробки та загоєння ран
BR102015029357A2 (pt) The use of bandages and membranes produced with quitosan and combined derivatives with various additives in the regeneration of injured fabrics and healing
UA65716A (en) Complex antibacterial sorption composition "benegol forte" for preventing anaerobic infection and treating purulent wounds, neurepathic eschar, and burns, method for its manufacture and application
WO2012108851A1 (ru) Композиция для лечения гнойных ран

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired